Sectors
GPCR
Structure Therapeutics Inc.
49.84
1 x 49.53
1 x 49.77
bid
ask
+
0.49
0.99%
10:34 AM
timesize
| Ytd | -28.34% | |
| 1y | 174.00% |
48.80
day range
49.95
15.80
52 week range
94.90
| Open | 48.80 | Prev Close | 49.35 | Low | 48.80 | High | 49.95 | Mkt Cap | 2.84B |
| Vol | 128.22K | Avg Vol | 797.91K | EPS | -1.57 | P/E | -31.43 | Forward P/E | -27.60 |
| Beta | -1.50 | Short Ratio | 6.71 | Inst. Own | 96.05% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 44.30 | 200-d Avg | 51.14 | 1yr Est | 104.59 |
| Income Statement | |||
| Operating Expenses | 89.38M | ||
| Research and Development Expense | 66.51M | ||
| Selling, General and Administrative Expense | 22.87M | ||
| Operating Income | -89.38M | ||
| Income Tax Expense | 190.00K | ||
| Net Income | -75.97M | ||
| Net Income Common Stock | -75.97M | ||
| Net Income Common Stock (USD) | -75.97M | ||
| Consolidated Income | -75.97M | ||
| Earnings per Basic Share | -1.05 | ||
| Earnings per Basic Share (USD) | -1.05 | ||
| Earnings per Diluted Share | -1.05 | ||
| Earning Before Interest & Taxes (EBIT) | -75.78M | ||
| Earning Before Interest & Taxes (USD) | -75.78M | ||
| Weighted Average Shares | 217.33M | ||
| Weighted Average Shares Diluted | 217.33M | ||
| Balance Sheet | |||
| Cash and Equivalents | 316.17M | ||
| Cash and Equivalents (USD) | 316.17M | ||
| Investments | 1.14B | ||
| Investments Current | 1.14B | ||
| Current Assets | 1.49B | ||
| Property, Plant & Equipment Net | 11.97M | ||
| Total Assets | 1.51B | ||
| Debt Current | 2.61M | ||
| Total Debt | 5.79M | ||
| Current Liabilities | 56.98M | ||
| Debt Non-Current | 3.18M | ||
| Total Liabilities | 61.03M | ||
| Accumulated Retained Earnings (Deficit) | -546.27M | ||
| Accumulated Other Comprehensive Income | -2.19M | ||
| Shareholders Equity | 1.45B | ||
| Shareholders Equity (USD) | 1.45B | ||
| Assets Non-Current | 17.53M | ||
| Total Debt (USD) | 5.79M | ||
| Liabilities Non-Current | 4.05M | ||
| Trade and Non-Trade Payables | 7.82M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.22M | ||
| Net Cash Flow from Financing | -1.74M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -483.45M | ||
| Capital Expenditure | -1.18M | ||
| Issuance (Purchase) of Equity Shares | 869.00K | ||
| Net Cash Flow from Investing | -496.95M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -495.76M | ||
| Net Cash Flow from Operations | 15.23M | ||
| Share Based Compensation | 11.64M | ||